measurement of Cllu1 can monitor for minimal residual disease in patients with chronic lymphocytic leukemia after therapy : V92
2010
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI